Latest News about fda
Recent news which mentions fda
Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years
December 26, 2023
From Benzinga
From Benzinga
From Benzinga
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
December 22, 2023
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
From Benzinga
FDA Refuses Neurology-Focused Clene's Accelerated Approval For Amyotrophic Lateral Sclerosis Treatment, Shares Fall
December 21, 2023
Tickers
CLNN
From Benzinga
New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel
December 21, 2023
Tickers
RDGL
From Benzinga
Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?
December 21, 2023
From Benzinga
Philips Recalls Medical Imaging Device Due To A Risk Of Explosion; FDA Identifies Recall As Most Serious Type
December 21, 2023
Tickers
PHG
From Benzinga
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
From Benzinga
From Benzinga
Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst
December 20, 2023
From Benzinga
Medtronic Issues Class I Recall For Its Surgical Navigation Software Due To Glitch
December 20, 2023
Tickers
MDT
From Benzinga
E-cigarette Player Juul's Latest Move: Submits FDA Application for Menthol Pods with Stringent Age Checks
December 20, 2023
Tickers
MO
From Benzinga
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
December 19, 2023
Tickers
ASND
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.